BioSpace News Archive

Integral Molecular, the industry leader in the discovery and characterization of antibodies against membrane proteins, announces the launch of ReadyMap services, an expansion of its Shotgun Mutagenesis Epitope Mapping platform for rapid mapping of antibody binding sites on pre-validated protein targets.

LEXINGTON, Mass. , Feb. 13, 2020 /PRNewswire/ -- Promedior, Inc. today announced the successful completion of its previously announced sale to Roche (SIX: RO, ROG; OTCQX: RHHBY). With this acquisition, Roche obtained full rights to Promedior’s entire portfolio of molecules for serious fibrotic diseases, notably PRM-151. Under the terms of the merger agreement, Roche made an up

In a strategic move to better capture opportunities to grow in other states, Mosaic (http://www.mosaicinfo.com), a Nebraska-based provider of personalized services to more than 3,700 people with diverse needs in 10 states, transitioned its Texas services to Caregiver Inc.

New training model helps build strong and healthy relationships for children and caregivers

- Universities awarded $250,000 research grants as part of the CSL Behring-Science Center Research Acceleration Initiative -

Feb. 13, 2020 14:15 UTC Experts to Share Insights on: Development of Patient-Centric, Diverse Trials Artificial Intelligence and Real-World Data Study Convenience and Compliance Analytics to Drive Decision-Making and Trial Efficiency NEW YORK--( BUSINESS WIRE )-- Medidata, the global leader in creating end-to-end solutions supporting the entire clinical trial process, and a Dassault Systèmes company, announced its participation in mul

NASHUA, N.H., Feb. 13, 2020 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the fourth quarter and year ended December 31, 2019, after the market close, and host a conference call at 4:30pm Eastern Time on Thursday, February 27. Thursday, February 27th @ 4:30pmET Domestic: 877-407-0784 International: 201-689

Feb. 13, 2020 14:30 UTC New molecular analyses to be presented at ASCO Genitourinary Cancers Symposium DURHAM, N.C.--( BUSINESS WIRE )-- GeneCentric Therapeutics today announced it will present two posters during the ASCO GU Cancers Symposium to be held in San Francisco, California, February 13-15, 2020. The data are derived from GeneCentric’s expertise in the identification of RNA-based Predictive Response Signatures and through collaborations with researchers at leading i

Feb. 13, 2020 13:00 UTC Initial Tranche Extends Cash Runway into 2022, Beyond Planned Clinical Data Readouts for Two Lead Programs CAMBRIDGE, Mass.--( BUSINESS WIRE )-- Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced the closing of a $60 million senior secured loan facility with Oxford Finance LLC, a specialty finance firm providing senior debt to life sciences and healthcare service compani

The annual pitch competition at SPIE Photonics West 2020 showcased two photonics-focused tracks for the first time, recognizing six winners in healthcare and deep tech